The company
Perspective Therapeutics, Inc.
CATX · NYSE American
CATX stood above a rising 150-day average in 16 of the last 52 weekly readings, and has been out of that trend for the last 20 weeks. It is 36.4% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 20
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $42K
- Insider sales, 12 months
- $3.2M
- Officials’ trades on record
- 0
- Institutions holding
- 127 (-4)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Lantheus Alpha Therapy, Llc10% owner | sold | 167,149at $3.15 | 4 Sep 2026filed 8 Sep 2026 |
| Lantheus Alpha Therapy, Llc10% owner | sold | 80,783at $3.11 | 3 Sep 2026filed 8 Sep 2026 |
| Lantheus Alpha Therapy, Llc10% owner | sold | 42,129at $3.11 | 2 Sep 2026filed 4 Sep 2026 |
| Lantheus Holdings, Inc.10% owner | sold | 35,769at $3.12 | 1 Sep 2026filed 3 Sep 2026 |
| Lantheus Alpha Therapy, Llc10% owner | sold | 35,769at $3.12 | 1 Sep 2026filed 4 Sep 2026 |
| Lantheus Holdings, Inc.10% owner | sold | 78,145at $3.14 | 31 Aug 2026filed 2 Sep 2026 |
| Lantheus Alpha Therapy, Llc10% owner | sold | 78,145at $3.14 | 31 Aug 2026filed 4 Sep 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 9,494,152$32.4M | +4,145,591+77.5% |
| TCG Crossover Management, LLCunchanged · filed 14 Aug 2026 | 7,915,567$27.0M | 00.0% |
| Commodore Capital LPunchanged · filed 14 Aug 2026 | 6,336,782$21.6M | 00.0% |
| Avidity Partners Management LPadded · filed 14 Aug 2026 | 6,299,999$21.5M | +250,000+4.1% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 6,051,771$20.6M | +2,919,101+93.2% |
| MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026 | 4,911,855$16.7M | +865,215+21.4% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 4,436,572$15.1M | +57,616+1.3% |
| Affinity Asset Advisors, LLCadded · filed 13 Aug 2026 | 4,214,582$14.4M | +1,050,000+33.2% |
| CITADEL ADVISORS LLCadded · filed 14 Aug 2026 | 3,805,739$13.0M | +239,235+6.7% |
| Spruce Street Capital LPadded · filed 13 Aug 2026 | 3,693,931$12.6M | +1,066,824+40.6% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.